Harbor scores a 75 on our Value Score. These are the top-ranked GLP-1 deals we'd point you to instead — every one scored on the same six factors, with the teaser-rate traps flagged so you pay the honest lower price.
✓No teaser step-up. VitaraRx is a direct-to-consumer telehealth marketplace offering compounded semaglutide and tirzepatide at flat per-drug pricing across all doses — no membership or hidden fees.
!Pricing to watch. Two of the lowest per-month figures in the ranking, held flat at every dose and unusually open about who fills them — but both are annual-plan rates, and no month-to-month price is published at all.
!Pricing to watch. Weekly compounded injections from $99 for semaglutide and $140 for tirzepatide, sold beside four other treatment categories - the prices are visible up front, but they are floors rather than fixed rates.
✓No teaser step-up. One price at every semaglutide dose, $106 a month, with the seller stating plainly that there are no membership fees - which is rarer than it should be at this end of the market.
⚠FDA warning letter. The FDA issued Glow Medispa, LLC dba Mint Med a warning letter in June 2026. Check it on the FDA database.
From $99/mo (starting dose, plus a separate fee, compounded)
Save ~93%
!Pricing to watch. Jyra Health is an online weight-loss and longevity telehealth clinic offering compounded GLP-1 — semaglutide from $99/mo and tirzepatide from $133/mo (limited time) — prescribed by board-certified providers.
!Pricing to watch. CoraDoc is a nationwide (all 50 states) doctor-prescribed GLP-1 weight-loss telehealth service offering compounded semaglutide (from $99/mo) and tirzepatide (from $165/mo) as flat, no-subscription programs.
✓No teaser step-up. Candor Rx (candorrx.com) is a GLP-1 telehealth service offering compounded semaglutide and tirzepatide with flat, dose-independent pricing.
!Pricing to watch. Fifty 410 is a direct-to-consumer weight-loss telehealth service offering personalized compounded semaglutide and tirzepatide prescribed by licensed providers.
⚠FDA warning letter. The FDA issued Aspen Aesthetics dba Fifty 410 a warning letter in February 2026. Check it on the FDA database.
Ranked by our Value Score — our editorial judgment per the methodology. “Save” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Assume any provider we list may compensate us — it never changes a Value Score. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.